Dendreon Corporation (NASDAQ:DNDN) receives authorization

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Dendreon Corporation (NASDAQ NDN) receives authorization and approval from the European Medicines Agency (EMA), Celsion Corporation (NASDAQ:CLSN)


Dendreon Corporation (NASDAQ NDN) is a biotechnology company primarily focusing on treating cancer. The company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics which will transform cancer treatment options into lives.

The company has announced that they have received authorization and approval from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) that PROVENGE can be marketed in the European Union to treat the patients suffering from Asymptomatic or Minimally Symptomatic Metastatic (non-visceral) castrate resistant prostate cancer which are commonly found in male adults and chemotherapy has not yet been clinically indicated in them. The CHMP’s recommendation was supported by a positive recommendation from the Committee for Advanced Therapy (CAT).

Mark Frohlich, the Executive Vice President of R & D and the Chief Medical Officer of Dendreon pleasingly said that they are happy with the outcome and are looking forward to the European Commission‘s final regulatory decision this year. He explained that PROVENGE is a novel therapy which helps the patients to meet their unmet needs, by using one’s own immune system to fight against cancer. He remarked that the said therapy is approved the same will help many lives to live a better healthy life ahead.  This is the first immunotherapy which has resulted in an overall improvement in prostate cancer patients. .

John H. Johnson, Dendreon’s Chairman, President CEO has said that the recommendation as mentioned above represents and signifies that the company is achieving a milestone and the company is engaged in global market opportunity for the said therapy.

Celsion Corporation (NASDAQ:CLSN) is primarily engaged in developing and commercializing certain innovative cancer drugs including tumor treatments which uses a combination of heat energy with heat activated liposomal drug technology. Celsion has certain products lined up which are under their clinical trial namely ThermoDox, in its Phase III being evaluated primarily for liver cancer, a Phase II Colorectal Liver Metastasis (CRLM) and a Phase II for recurrent chest wall breast cancer.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Huawei's Financial AI Push Targets Scale, Not Demos

Updated Category News Views 79

Banking AI has reached the point where a clever chatbot barely moves the needle. Huawei's message at Singapore FinTech Festival 2026 was aimed squarely at that harder, more expensive problem: turning AI from a scattered pilot project into machinery a financial institution can operate, govern, repeat, and improve without handing over its crown jewels. Ownership Is the...

Continue Reading
VIGGO’s Mix1Pro Tests Practical Commercial Cleaning

Updated Category News Views 53

A cleaning robot earns its keep in the ugly corners, not under convention-center lights. VIGGO used the ISSA Show North America gathering in Las Vegas, held November 17–19, 2026, to introduce the Mix1Pro, a compact commercial machine aimed at indoor facilities below 53,800 square feet. That target matters. Smaller, messier sites are where autonomy can look terrific on a...

Continue Reading
Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 44

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 25

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 31

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 464

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 113

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 66

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading

Top 5 Most Recently Viewed Articles

Duos Technologies Secures $40 Million Offering for Growth

Updated Category News Views 263

Duos Technologies Announces Successful Pricing of Public Offering Duos Technologies Group, Inc. (Nasdaq: DUOT) has successfully priced its public offering of common stock, raising $40 million to expand its operations and address its ambitious revenue goals. Overview of the Offering In a recent announcement, Duos unveiled that it will be offering 6,666,667 shares of its...

Continue Reading
Understanding TELUS Intl's Upcoming Earnings Report

Updated Category News Views 170

TELUS Intl Quarterly Earnings Overview TELUS Intl (TIXT) is preparing to unveil its quarterly earnings report, sparking interest among investors keen on understanding the company's performance and future outlook. As we approach the announcement, anticipation grows regarding the possible results and guidance. Investor Expectations Analysts have set their eyes on TELUS...

Continue Reading
America's Car-Mart Reports Q1 Results and Strategic Focus

Updated Category News Views 70

America's Car-Mart Focuses on Strategic Growth Amid Revenue Declines America's Car-Mart Inc. (NASDAQ: CRMT), a leading automotive retailer in the United States, has recently released its financial results for the first quarter of fiscal 2025. The company reported a revenue decline of 5.2%, primarily due to a decrease in retail units sold. However, America's Car-Mart is...

Continue Reading
Kayne Anderson Energy Infrastructure Fund Declares New Share Distribution

Updated Category News Views 108

Distribution Announcement from Kayne Anderson Energy Infrastructure Fund Kayne Anderson Energy Infrastructure Fund, Inc. has officially announced a monthly distribution of $0.08 per share. This upcoming payment is scheduled for common stockholders and highlights the fund's commitment to providing returns to its investors. Details of the Monthly Distribution The...

Continue Reading
Giftify, Inc. Celebrates Revenue Growth and Strategic Advancements

Updated Category News Views 249

Revenue Highlights and Profit Growth Giftify, Inc. (NASDAQ: GIFT), a major player in the incentives and rewards industry, reported impressive financial results for the first quarter. The company's revenue soared by 3.5%, reaching $22.3 million, demonstrating its resilience in a competitive market. Moreover, the company's gross profit increased by 10%, now standing at $3.6...

Continue Reading